A pharmacokinetic (PK) study to determine the performance of AP-CD/LD compared to Sinemet

Trial Profile

A pharmacokinetic (PK) study to determine the performance of AP-CD/LD compared to Sinemet

Planning
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2018

At a glance

  • Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 15 Mar 2018 New trial record
    • 09 Mar 2018 According to a Intec Pharma media release, the Company expects that these results will be available in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top